bay1093884
mAbexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 28, 2015 (NCT02571569)
Timeline
Indications
Studied for
Mechanism of action
- Tissue factor pathway inhibitorINHIBITOR
TFPI inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- bay1093884
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03996486 | Phase 1 | Jul 1, 2019 | Bayer |
| NCT03597022 | Phase 2 | Jul 24, 2018 | Bayer |
| NCT03481946 | Phase 1 | May 10, 2018 | Bayer |
| NCT02571569 | Phase 1 | Oct 28, 2015 | Bayer |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bayer | For profit | 4 | 4 | 2 | 2015 |
1 organizations
Page 1 / 1